Minerals Technologies Inc (MTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Minerals Technologies Inc (MTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH31412FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Minerals Technologies Inc (MTX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Minerals Technologies Inc (MTI) is a resource and technology based company that develops, produces, and markets a wide range of specialty mineral, mineral-based, and synthetic mineral products, and associated systems and services. The company also provides monolithic and shaped refractory materials and specialty products, application and measurement equipment, and calcium metal and metallurgical wire products for high-temperature applications. These products find use in paper, building materials, paint and coatings, steel, non-ferrous metal, glass, ceramic, polymer, food, automotive, and pharmaceutical industries. The company has operations in Singapore, Indonesia, China, Thailand, the UK, Germany, Portugal, Malaysia, South Africa and Mexico. MTI is headquartered in New York, the US.

Minerals Technologies Inc Key Recent Developments

Feb 04,2021: Minerals technologies reports fourth quarter 2020 earnings of $0.91 per share, or $1.08 per share, excluding special items
Nov 12,2020: Minerals Technologies announcement regarding Elementis
Oct 29,2020: Minerals Technologies reports third quarter 2020 earnings of $0.83 per share, or $0.92 per share, excluding special items
Aug 31,2020: Minerals Technologies appoints Erin Cutler as vice president, human resources
Jul 30,2020: Minerals Technologies reports second quarter 2020 earnings of $0.42 per share, or $0.85 per share, excluding special items

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Minerals Technologies Inc – Key Facts
Minerals Technologies Inc – Key Employees
Minerals Technologies Inc – Key Employee Biographies
Minerals Technologies Inc – Major Products and Services
Minerals Technologies Inc – History
Minerals Technologies Inc – Company Statement
Minerals Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Minerals Technologies Inc – Business Description
Business Segment: Energy Services
Overview
Performance
Business Segment: Performance Materials
Overview
Performance
Business Segment: Refractories
Overview
Performance
Business Segment: Specialty Minerals
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Canada/Latin America
Performance
Geographical Segment: Europe/Africa
Performance
Geographical Segment: United States
Performance
R&D Overview
Minerals Technologies Inc – Corporate Strategy
Minerals Technologies Inc – SWOT Analysis
SWOT Analysis – Overview
Minerals Technologies Inc – Strengths
Minerals Technologies Inc – Weaknesses
Minerals Technologies Inc – Opportunities
Minerals Technologies Inc – Threats
Minerals Technologies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Feb 04, 2021: Minerals technologies reports fourth quarter 2020 earnings of $0.91 per share, or $1.08 per share, excluding special items
Oct 29, 2020: Minerals Technologies reports third quarter 2020 earnings of $0.83 per share, or $0.92 per share, excluding special items
Aug 31, 2020: Minerals Technologies appoints Erin Cutler as vice president, human resources
Jul 30, 2020: Minerals Technologies reports second quarter 2020 earnings of $0.42 per share, or $0.85 per share, excluding special items
Jun 23, 2020: Minerals Technologies announces private offering of $400 Million of senior notes
May 21, 2020: Minerals Technologies inks agreement with Satia Industries to construct 42,000 metric ton per year satellite PCC plant in India
Apr 30, 2020: Minerals Technologies Reports First Quarter 2020 Earnings of $1.12 Per Share, or $1.13 Per Share, Excluding Special Items
Apr 08, 2020: Minerals Technologies Provides COVID-19 Business Update
Jan 30, 2020: Minerals Technologies reports fourth quarter 2019 earnings of $0.83 per share, or $0.95 per share, excluding special items
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Minerals Technologies Inc, Key Facts
Minerals Technologies Inc, Key Employees
Minerals Technologies Inc, Key Employee Biographies
Minerals Technologies Inc, Major Products and Services
Minerals Technologies Inc, History
Minerals Technologies Inc, Subsidiaries
Minerals Technologies Inc, Key Competitors
Minerals Technologies Inc, Ratios based on current share price
Minerals Technologies Inc, Annual Ratios
Minerals Technologies Inc, Annual Ratios (Cont...1)
Minerals Technologies Inc, Annual Ratios (Cont...2)
Minerals Technologies Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Minerals Technologies Inc (MTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IDBI Bank Ltd:企業の戦略・SWOT・財務情報
    IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Co-operative Bank Plc:企業の戦略・SWOT・財務情報
    The Co-operative Bank Plc - Strategy, SWOT and Corporate Finance Report Summary The Co-operative Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ultragenyx Pharmaceutical Inc (RARE):企業の財務・戦略的SWOT分析
    Ultragenyx Pharmaceutical Inc (RARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Peptimimesis SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptimimesis SAS (Peptimimesis) is a biopharmaceutical company that discovers and develops transmembrane therapeutic peptides. The company’s proprietary platform delivers a set of drug candidates that act on strategic targets in the field of immuno-oncology, oncology and immune diseases. Its …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) is a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cement, fert …
  • Ferrovial, S.A.:企業の戦略・SWOT・財務情報
    Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report Summary Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Valentino Fashion Group S.p.A:企業の戦略・SWOT・財務情報
    Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report Summary Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nohmi Bosai Ltd:企業の戦略・SWOT・財務情報
    Nohmi Bosai Ltd - Strategy, SWOT and Corporate Finance Report Summary Nohmi Bosai Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Diffusion Pharmaceuticals Inc (DFFN):企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • PT Kideco Jaya Agung:企業の戦略・SWOT・財務情報
    PT Kideco Jaya Agung - Strategy, SWOT and Corporate Finance Report Summary PT Kideco Jaya Agung - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Wells Fargo Clearing Services LLC:企業の戦略・SWOT・財務分析
    Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Anpario Plc (ANP):企業の財務・戦略的SWOT分析
    Summary Anpario Plc (Anpario), formerly Kiotech International Plc is a producer and distributor of natural feed additives for animal health, hygiene and nutrition. The company develops products for poultry, pig, ruminant and animal feed markets that include acidifiers, essential oils, enzymes, pelle …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • Energisa SA (ENGI11):電力:M&Aディール及び事業提携情報
    Summary Energisa SA (Energisa) is a power utility that generates, distributes and sells electricity. The company generates electricity through wind, small hydropower, and biomass resources. It also operates and maintains hydroelectric power plants for other companies; constructs and refurbishes gene …
  • Mitsubishi Tanabe Pharma Corp (4508):企業の財務・戦略的SWOT分析
    Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • StealthGas Inc (GASS):企業の財務・戦略的SWOT分析
    Summary StealthGas Inc (StealthGas) is an oil and gas shipping company that offers seaborne and oil and gas transportation services. The company provides transportation of petroleum and petrochemical gas products in liquefied forms. It transports byproducts of crude oil and natural gas including but …
  • United BioPharma Inc (6471):製薬・医療:M&Aディール及び事業提携情報
    Summary United BioPharma Inc (United BioPharma) is a pharmaceutical company. The company develops, manufactures, and markets monoclonal antibody (mAb) products and biosimilar antibodies. Its molecules product pipeline includes UB-421, a monoclonal antibody for AIDS treatment; and UB-621, an anti-her …
  • Swiss Life Holding Ltd:企業の戦略・SWOT・財務情報
    Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MDU Resources Group Inc (MDU):企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Medison Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Medison Pharma Ltd (Medison) is a drug company that develops and manufactures medical products. The company's oncology products include vectibix, myocet, aranesp, symphony and coloprint. Its neurology products are avonex, tysabri, fampyra, provigil, stryker, dysport and firdapse. Medison off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆